FDA Approves Merck's First Daily Pill to Drastically Lower LDL Cholesterol in High-Risk Patients

Washington Times—The Food and Drug Administration approved Merck's new cholesterol-lowering medication, the first daily oral pill of its kind designed to substantially reduce LDL levels in high-risk cardiovascular patients. The drug represents a novel class of cholesterol treatment, distinct from existing statins and injectable PCSK9 inhibitors. Clinical trials showed meaningful reductions in LDL when the pill was added to existing treatment regimens. Cardiologists called it a significant option for patients who cannot tolerate statins or who require additional LDL reduction.

• Washington Times — FDA approves a first-of-its-kind pill to cut cholesterol in high-risk patients
• ABC News — Health — FDA approves a first-of-its-kind pill to cut cholesterol in high-risk patients
• NBC News — Health — FDA approves new kind of cholesterol pill
• NBC News — Health — New FDA-Approved Pill Drastically Lowers Bad Cholesterol
• The Hill — The FDA approved the first daily pill to drastically lower cholesterol levels
• Reuters — Merck's new cholesterol pill received US FDA approval
• New York Times — The F.D.A. Approves a New Pill to Slash Cholesterol Levels
• CNBC — Merck's cholesterol pill gets U.S. FDA approval